Government Relations Update - February 2024
Government Relations Update – February 2024
Government Relations Update – February 2024
WASHINGTON, D.C.— December 31, 2021 — In response to additional rulemaking for the Centers for Medicare & Medicaid Services’ (CMS) Notice of Benefit and Payment Parameters (NBPP
Media Contact:
Ilana Ostrin
212 328 3769
CSL Behring announced that the company’s distribution agreement with Ferring Pharmaceuticals for STIMATE® nasal spray recently expired and will not be renewed effectively removing this medication as a valuable treatment opti
Media Contact:
Brett Spitale, VP of Advancement
bspitale@hemophilia.org
646-784-0368
FOR PUBLIC COMMENT - JUNE 3, 2021
The National Hemophilia Foundation is thrilled to announce that its top legislative priority in 2020, The Hemophilia SNF Access Act, was included in the end-of-year omnibus federal spending and economic relief package passed by Congress on December 21, 2020 (HR 133, The Consolidated Appropriation